Re: “A Follow-Up Strategy for Patients with Excellent Response to Initial Therapy for Differentiated Thyroid Carcinoma” by Jeon et al . ( Thyroid 2018;28:187–192)
Restricted accessLetterFirst published online April, 2018
Re: “A Follow-Up Strategy for Patients with Excellent Response to Initial Therapy for Differentiated Thyroid Carcinoma” by Jeon et al . ( Thyroid 2018;28:187–192)
WangLY, RomanBR, MigliacciJC, PalmerFL, TuttleRM, ShahaAR, ShahJP, PatelSG, GanlyI. 2015. Cost-effectiveness analysis of papillary thyroid cancer surveillance. Cancer, 121:4132–4140.
2.
JeonMJ, KimM, ParkS, OhHS, KimTY, KimWB, ShongYK, KimWG. 2018. A follow-up strategy for patients with excellent response to initial therapy for differentiated thyroid carcinoma: less is better. Thyroid, 28:187–192.
3.
RosarioPW, MouraoGF, CalsolariMR. 2016. Can the follow-up of patients with papillary thyroid carcinoma of low and intermediate risk and excellent response to initial therapy be simplified using second-generation thyroglobulin assays?. Clin Endocrinol, 85:596–601.
4.
Souza CortêsMC, RosarioPW, Faria OliveiraLF, CalsolariMR. 2018. Clinical impact of detectable antithyroglobulin antibodies below the reference limit (borderline) in patients with papillary thyroid carcinoma with undetectable serum thyroglobulin and normal neck ultrasonography after ablation: a prospective study. Thyroid, 28:229–235.
5.
SpencerC, PetrovicI, FatemiS. 2011. Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab, 96:1283–1291.
6.
HaugenBR, AlexanderEK, BibleKC, DohertyGM, MandelSJ, NikiforovYE, PaciniF, RandolphGW, SawkaAM, SchlumbergerM, SchuffKG, ShermanSI, SosaJA, StewardDL, TuttleRM, WartofskyL. 2016. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 26:1–133.
